Ryll Thomas 4
4 · IMMUNOGEN INC · Filed Feb 4, 2019
Insider Transaction Report
Form 4
IMMUNOGEN INCIMGN
Ryll Thomas
VP, Technical Operations
Transactions
- Award
Stock Option (right to buy)
2019-01-31$5.25/sh+221,900$1,164,975→ 221,900 totalExercise: $5.25From: 2020-01-31Exp: 2029-01-31→ Common Stock (221,900 underlying)
Footnotes (1)
- [F1]Exercisable in three equal installments over the next three years starting on the first year anniversary of the grant.